<PAGE>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON D.C. 20549

                                    FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2002

                                       OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
                                  ACT OF 1934

FOR THE TRANSITION PERIOD FROM ................. TO ..................

COMMISSION FILE NUMBER  1-12607

                          SUNLINK HEALTH SYSTEMS, INC.
             ------------------------------------------------------
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                    Ohio                                        31-0621189
                  ---------                                    -------------
(STATE OR OTHER JURISDICTION OF INCORPORATION                (I.R.S. EMPLOYER
                OR ORGANIZATION)                            IDENTIFICATION NO.)

            900 Circle 75 Parkway, Suite 1300, Atlanta, Georgia 30339
            ---------------------------------------------------------
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
                                   (ZIP CODE)

                                 (770) 933-7000
                                 --------------
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)


         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filings requirements for the past 90 days.


Yes   [X]      No  [ ]



         The number of Common Shares, without par value, outstanding as of
February 10, 2003 was 4,997,592.

<PAGE>


PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

                                   SUNLINK HEALTH SYSTEMS, INC. AND SUBSIDIARIES
                                       CONDENSED CONSOLIDATED BALANCE SHEETS
                                                   (IN THOUSANDS)

<TABLE>
<CAPTION>
                                                                      DECEMBER 31,             JUNE 30,
                                                                         2002                    2002
                                                                       --------                --------
                                                                     (UNAUDITED)
<S>                                                                  <C>                      <C>
                                 ASSETS
                                 ------

Current Assets:
   Cash and cash equivalents                                           $    468                $  5,719
   Receivables - net                                                     11,103                  10,857
   Medical supplies                                                       1,811                   1,774
   Prepaid expenses and other                                             1,235                   1,212
                                                                       --------                --------
     Total Current Assets                                                14,617                  19,562

Property, Plant and Equipment, At Cost                                   36,441                  30,457
   Less accumulated depreciation and amortization                         2,365                   1,861
                                                                       --------                --------
     Property, Plant and Equipment - Net                                 34,076                  28,596

Other Assets                                                                448                     413
                                                                       --------                --------

           Total Assets                                                $ 49,141                $ 48,571
                                                                       ========                ========

                  LIABILITIES AND SHAREHOLDERS' EQUITY
                  ------------------------------------

Current Liabilities:
   Accounts payable                                                    $  5,853                $  3,988
   Third-party payor settlements                                          4,735                   5,088
   Current maturities of long-term debt                                     986                     940
   Accrued expenses                                                       6,188                   6,331
   Net current liabilities of discontinued operations                       164                     164
                                                                       --------                --------
     Total Current Liabilities                                           17,926                  16,511

Long-Term Liabilities:
   Long-term debt                                                        23,144                  23,281
   Noncurrent liability for professional liability risks                  1,117                   1,151
   Noncurrent liabilities of discontinued operations                      1,597                   1,673
                                                                       --------                --------
     Total Long-term Liabilities                                         25,858                  26,105

Shareholders' Equity:
   Common shares, without par value:
     Issued and outstanding, 4,998 at December 31, 2002
       and June 30, 2002                                                  2,499                   2,499
   Additional paid-in capital                                             3,628                   3,628
   Retained earnings (deficit)                                             (384)                    167
   Accumulated other comprehensive loss                                    (386)                   (339)
                                                                       --------                --------
     Total Shareholders' Equity                                           5,357                   5,955
                                                                       --------                --------

           Total Liabilities and Shareholders' Equity                  $ 49,141                $ 48,571
                                                                       ========                ========
</TABLE>

See notes to condensed consolidated financial statements.



                                        2
<PAGE>

                    SUNLINK HEALTH SYSTEMS, INC. AND SUBSIDIARIES
                    CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
                   (in thousands, except per share amounts)
                                  (unaudited)

<TABLE>
<CAPTION>
                                                                 THREE MONTHS ENDED                      SIX MONTHS ENDED
                                                                    DECEMBER 31,                            DECEMBER 31,
                                                        ------------------------------------    ----------------------------------
                                                                 2002               2001                  2002             2001
                                                        ------------------------------------    ----------------------------------
<S>                                                     <C>                        <C>          <C>                      <C>
Net Revenues                                                     $ 23,675          $ 21,590              $ 47,476        $ 43,139

Operating Expenses:
  Salaries, wages and benefits                                     11,270            10,709                22,143          21,502
  Provision for bad debts                                           2,530             2,569                 5,320           5,391
  Supplies                                                          2,740             2,326                 5,461           4,757
  Purchased services                                                1,841             1,864                 3,737           3,646
  Other operating expenses                                          3,087             2,855                 6,420           5,681
  Rent and lease expense                                              539               533                 1,096           1,056
  Depreciation and amortization                                       362               329                   718             617
  Merger expenses                                                     411                 -                   411              --
  Asset impairment charge                                           1,562                 -                 1,562              --
  Gain on sale of property and equipment                                -              (310)                    -            (329)
                                                        -----------------------------------     ---------------------------------

Operating Profit (Loss)                                              (667)              715                   608             818

Other Income (Expense):
  Interest expense                                                   (592)             (694)               (1,341)         (1,403)
  Interest income                                                      24                 5                    40              19
                                                        -----------------------------------     ---------------------------------

  Earnings (Loss) From Continuing Operations
    before Income Taxes                                            (1,235)               26                  (693)           (566)

Income Tax Expense                                                     67                 -                   159              --
                                                        -----------------------------------     ---------------------------------

Earnings (Loss) From Continuing Operations                         (1,302)               26                  (852)           (566)

Discontinued Operations:
  Earnings (Loss) from operations of Life Sciences
    and Engineering Segment                                           (15)              839                   (30)            831

  Earnings (Loss) on disposal of Housewares Segment                   331               (84)                  331             170
                                                        -----------------------------------     ---------------------------------

Earnings (Loss) from Discontinued Operations                          316               755                   301           1,001
                                                        -----------------------------------     ---------------------------------

    Net Earnings (Loss)                                            $ (986)            $ 781                $ (551)          $ 435
                                                        ===================================     =================================

Earnings (Loss) Per Share:
  Continuing Operations:
    Basic                                                         $ (0.26)           $ 0.01               $ (0.17)        $ (0.11)
                                                        ===================================     =================================
    Diluted                                                       $ (0.26)           $ 0.00               $ (0.17)        $ (0.11)
                                                        ===================================     =================================

  Net Earnings:
    Basic                                                         $ (0.20)           $ 0.16               $ (0.11)         $ 0.09
                                                        ===================================     =================================
    Diluted                                                       $ (0.20)           $ 0.15               $ (0.11)         $ 0.09
                                                        ===================================     =================================

Weighted-Average Common Shares Outstanding:
    Basic                                                           4,998             4,976                 4,998           4,976
                                                        ===================================     =================================
    Diluted                                                         4,998             5,277                 4,998           4,976
                                                        ===================================     =================================
</TABLE>


See notes to condensed consolidated financial statements.


                                        3
<PAGE>

                  SUNLINK HEALTH SYSTEMS, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (IN THOUSANDS)
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                      SIX MONTHS ENDED
                                                                                         DECEMBER 31,
                                                                           -----------------------------------
                                                                                  2002                  2001
                                                                           -----------------------------------
<S>                                                                        <C>                        <C>
Net Cash Provided by Operating Activities                                      $ 1,017                $   985

Cash Flows From Investing Activities:
   Expenditures for property, plant and equipment                               (5,806)                (2,084)
   Proceeds from sale of LTS Holdings preferred stock                               --                    850
   Proceeds from sale of property, plant and equipment                              --                  1,863
                                                                           ----------------------------------

     Net Cash Provided by (Used in) Investing Activities                        (5,806)                   629

Cash Flows From Financing  Activities:
   Payment of debt                                                                (462)                (4,000)
                                                                           ----------------------------------

     Net Cash Used in Financing Activities                                        (462)                (4,000)

   Effect of Exchange Rate Changes on Cash                                          --                      4
                                                                           ----------------------------------

Net Decrease in Cash and Cash Equivalents                                       (5,251)                (2,382)

Cash and Cash Equivalents at Beginning of Period                                 5,719                  3,540
                                                                           ----------------------------------

Cash and Cash Equivalents at End of Period                                     $   468                $ 1,158
                                                                           ==================================

Supplemental Disclosure of Cash Flow Information:

Cash Paid For:
     Interest, net of amounts capitalized                                      $    48                $   321
                                                                           ==================================
     Income taxes                                                              $    80
                                                                           ===========

Noncash Investing and Financing Activities:

   Long-term debt issued as payment-in-kind for interest payable               $   807                $ 1,031
                                                                           ==================================
</TABLE>

See notes to condensed consolidated financial statements.



                                       4
<PAGE>


                          SUNLINK HEALTH SYSTEMS, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                      THREE MONTHS ENDED DECEMBER 31, 2002
                             (DOLLARS IN THOUSANDS)
                                   (UNAUDITED)
NOTE 1. - BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements as of and
for the three and six months ended December 31, 2002 have been prepared in
accordance with Rule 10-01 of Regulation S-X of the Securities and Exchange
Commission and, as such, do not include all information required by accounting
principles generally accepted in the United States of America. These Condensed
Consolidated Financial Statements should be read in conjunction with the
consolidated financial statements included in the SunLink Health Systems, Inc.
("SunLink" or the "Company") Annual Report on Form 10-K for the fiscal year
ended June 30, 2002, filed on September 16, 2002. In the opinion of management,
the Condensed Consolidated Financial Statements, which are unaudited, include
all adjustments, consisting only of normal recurring adjustments, necessary to
present fairly the financial position and results of operations for the periods
indicated. The results of operations for the three and six months ended December
31, 2002 are not necessarily indicative of the results that may be expected for
the entire fiscal year or any other interim period.

NOTE 2. - BUSINESS OPERATIONS AND CORPORATE STRATEGY

SunLink is a provider of healthcare services through the operation of community
hospitals in the United States. In February 2001, SunLink acquired its existing
hospitals and began healthcare operations. Through its subsidiaries, SunLink
operates a total of six community hospitals in four states. Five of the
hospitals are owned and one is leased. SunLink also operates certain related
businesses, consisting primarily of nursing homes located adjacent to, or in
close proximity, with certain of its hospitals, and home health agencies
servicing areas around its hospitals. The healthcare operations comprise a
single business segment: community hospitals. SunLink currently does not have
operations in other business segments. SunLink's hospitals are acute care
hospitals and have a total of 333 licensed beds.

SunLink's business strategy is to focus its efforts on internal growth of its
six existing hospitals supplemented by growth from selected hospital
acquisitions. During the quarter ended December 31, 2002, SunLink concentrated
its efforts on the operation and improvement of its six hospitals, and, as
discussed in Note 3, the planned merger with HealthMont, Inc., but continued to
evaluate certain hospitals which were for sale and reviewed selected hospitals
which SunLink determined might become available for sale.

NOTE 3. - POTENTIAL MERGER WITH HEALTHMONT, INC.

On October 15, 2002, SunLink announced that it and a wholly owned subsidiary of
SunLink had signed a definitive merger agreement to acquire all of the
outstanding capital stock of HealthMont, Inc. ("HealthMont"), a privately held
operator of community hospitals. If the transaction is consummated, SunLink
would acquire two community hospitals: Memorial Hospital of Adel, a 60-bed
acute-care facility in Adel, Georgia, which includes a 95-bed nursing home, and
Callaway Community Hospital, a 49-bed acute-care hospital in Fulton, Missouri.
HealthMont currently operates another community hospital in San Benito, Texas,
which is to be sold prior to the completion of the merger. Upon completion of
the merger, the Company would operate eight community hospitals with a total of
442 beds.

Under the terms of the merger agreement, SunLink would, among other things,
issue to the shareholders of HealthMont up to 1,155,000 common shares of SunLink
in consideration for all


                                       5
<PAGE>

issued and outstanding capital stock of HealthMont. HealthMont currently has
approximately 120 shareholders and approximately 6,248,000 HealthMont shares are
expected to be outstanding immediately prior to closing. Accordingly, each
HealthMont shareholder is expected to receive one common share of SunLink for
each 5.4083 HealthMont shares (approximately 0.1849 of a common share of SunLink
for each share of HealthMont).

In addition, SunLink would issue 95,000 common shares in connection with the
transaction to settle certain contractual obligations of HealthMont to its
officers and directors. SunLink would also become obligated to issue
approximately 20,000 common shares upon exercise of outstanding HealthMont
options.

In connection with the transaction, SunLink also currently would assume up to a
total of $9,800 (consisting of a senior credit facility of approximately $8,900
and capital leases, primarily for equipment, of approximately $900) in
HealthMont debt and enter into a $3,000, 3-year term loan that will be used for
the repayment of $600 of HealthMont's senior debt at closing, payment of certain
transaction costs and for working capital. The loan will bear interest at 15%
per annum and will require SunLink to pay certain fees. SunLink will also issue
warrants to purchase 75,000 of its common shares at an exercise price of $0.01
per share.

Subject to a number of conditions, HealthMont obtained the consent of its senior
lender to the proposed merger of HealthMont by SunLink and the modification of
certain terms of HealthMont's senior debt, including the principal repayment of
$600 at the closing of the merger and an extension of the maturity date of the
remaining debt to August 31, 2005. Post merger, the remaining senior debt is
expected to be comprised of term loans of approximately $5,000 with interest at
prime plus 2% per annum and revolving credit loans of approximately $3,900 with
interest at prime plus 1 1/2%. Upon completion of the merger, HealthMont's
senior lender would hold warrants to purchase 27,000 shares of SunLink's common
shares at an exercise price of $0.01 per share. Certain HealthMont investors
have arranged letters of credit which support up to $1,650 of HealthMont's
revolving credit loans. Subject to completion of the merger, SunLink has agreed,
in the event the letters of credit are drawn and the proceeds are used to the
outstanding balance of the revolving credit loans, to issue to such letter of
credit obligors 350,000 of SunLink's common shares in full satisfaction of
HealthMont's reimbursement obligations under the letters of credit. SunLink
would also pay to such letter of creditor obligors a 5% commitment fee annually
through August 31, 2005 in consideration of their obligations to maintain the
letters of credit.

Based on the average market price of SunLink's common shares of $2.41 per share
calculated based on the price two days before, the day of and two days after the
merger agreement was entered into, plus the amount of senior debt and capital
lease obligations expected to be assumed, plus currently estimated transaction
costs, the price to SunLink of the transaction would be approximately $14,700.

Subject to certain conditions, the merger agreement on its stated terms provides
on its stated terms that it is cancelable by either party if not completed by
January 31, 2003. On January 28, 2003, SunLink notified HealthMont of its
position that, as a result of delays attributable to preparation of the
HealthMont financial information for the merger Proxy/Registration statement,
HealthMont does not have the ability to terminate the merger agreement without
cause. HealthMont has disagreed with SunLink's position but has not notified
SunLink it intends to cancel the merger agreement.

On January 29, 2003, SunLink filed its preliminary Proxy/Registration on Form
S-4 with the Securities and Exchange Commission and preliminarily scheduled a
special shareholders' meeting for March 27, 2003 to vote on the proposed merger.


                                       6
<PAGE>

On January 30, 2003, SunLink received a letter from HealthMont purporting to
conclude that an merger proposal HealthMont received from a third party was a
superior proposal within the terms of the merger agreement. SunLink believes the
valuation ascribed to the competing proposal was flawed in several material
respects and is evaluating the information provided by HealthMont. Accordingly,
SunLink has not determined that HealthMont has, in fact, received a superior
proposal.

Although the merger agreement remains in full force and effect, capitalized
costs of $411 relating to the merger through December 31, 2002 have been
expensed in the quarter ended December 31, 2002 because SunLink currently can no
longer determine that it is probable that the HealthMont merger will be
completed. SunLink anticipates additional expenses related to the proposed
merger of HealthMont that were incurred subsequent to December 31, 2002 of
approximately $200 will be expensed during the quarter ended March 31, 2003.

SunLink and HealthMont have engaged in discussions concerning possible
amendments to the merger agreement, as well as possible financial support of
HealthMont by SunLink to enable HealthMont to continue its current operations
until the merger can be completed. No specific additional agreements or
modifications to the merger agreement have been reached and no assurances can be
given that any additional agreements or any modifications to the merger
agreement will be reached, or that the merger will be completed. Completion of
the merger is subject to a number of conditions, including regulatory approvals,
approval of the transaction by the shareholders of both SunLink and HealthMont
and modification of the terms of HealthMont's existing senior debt or
availability to SunLink of alternative financing.

The unaudited net revenues of the two HealthMont facilities to be acquired
through the merger were approximately $28,200, as reported by HealthMont for the
twelve months ended March 31, 2002. SunLink does not plan to add any corporate
staff or to significantly increase its overhead as a result of the merger.
SunLink will not acquire HealthMont's corporate staff and facilities in
connection with the merger.

Upon consummation of the merger, the board of directors of SunLink intends to
elect Gene Burleson, a current HealthMont director, to the unexpired the term of
Ronald J. Vannuki, who would step down from the Company's board. SunLink also
has agreed to nominate Mr. Burleson for election by its shareholders to a
two-year term on its board of directors at its 2003 Annual Meeting.

NOTE 4. - RECEIVABLES- NET

<TABLE>
<CAPTION>
                                                             DECEMBER 31,              JUNE 30,
                                                                 2002                    2002
                                                               --------                --------
<S>                                                          <C>                       <C>
Patient accounts receivable                                    $ 16,317                $ 16,269

Less allowance for doubtful accounts                             (5,545)                 (5,648)
                                                               --------                --------

Patient accounts receivable, (net of allowances)                 10,772                  10,621

Other accounts receivable                                           331                     236
                                                               --------                --------

         Total                                                 $ 11,103                $ 10,857
                                                               ========                ========
</TABLE>


                                       7
<PAGE>

         Net revenues included $898 and $0 for the three months ended December
31, 2002 and 2001, respectively, and $898 and $43 for the six months ended
December 31, 2002 and 2001, respectively, for the settlements and filings of
prior year Medicare and Medicaid cost reports. Net revenues decreased by $383
during the three and six months ended December 31, 2002 due to a payment in
settlement of a Medicaid indigent care issue.

NOTE 5. - IMPAIRMENT OF LONG-LIVED ASSET

The Company is currently building a new hospital in Jasper, Georgia, which will
replace its existing Mountainside Medical Center hospital. The new hospital is
scheduled to begin operations in May 2003. In August 2001, the FASB issued SFAS
No. 144, Impairment or Disposal of Long-Lived Assets. The provisions of this
statement provide a single accounting model for the impairment or disposal of
long-lived assets. As required by SFAS No. 144, SunLink adopted this new
accounting standard on July 1, 2002. During the quarter ended December 31, 2002,
SunLink determined that the carrying value of the Mountainside Medical Center
hospital and an adjacent medical office building exceeded their estimated fair
value by $1,482 and $80, respectively. An impairment loss of $1,562 was recorded
to write the hospital and the medical office center down to fair value based on
outside appraisals.

NOTE 6. - DISCONTINUED OPERATIONS

Housewares Segment - SunLink sold its former U.K. housewares subsidiary, Beldray
Limited ("Beldray"), on October 5, 2001 for nominal consideration. For the three
and six months ended December 31, 2002, a gain from discontinued operations of
$331 relating to a domestic capital loss tax carry-back was reported as a gain
on the disposal of the housewares segment. This capital loss carry-back resulted
from carrying-back capital losses on SunLink's investment in Beldray against
capital gains of earlier years. During the three months ended December 31, 2001,
a loss from discontinued operations of $84 related to the disposal of the
housewares segment was reported. The loss resulted from adjustments to the
foreign currency translation adjustment component of SunLink's shareholders'
equity related to the housewares segment. For the six months ended December 31,
2001, a gain of $170 resulted from realized currency gains on certain
transactions and adjustments to the foreign currency translation adjustment
component of SunLink's shareholders' equity related to the housewares segment.
Revenues of Beldray were $6,098 for the six months ended December 31, 2001.

Life Sciences and Engineering Segment - On November 5, 2001, the Company sold
its senior preferred stock of LTS Holdings Inc., the parent company of Wyle
Laboratories, Inc. to LTS Holdings Inc. for $850 cash. The Company acquired the
senior preferred stock in November 1999 in connection with the sale of its
interest in Wyle to LTS Holdings, Inc. Earnings from discontinued operations of
this segment of $839 for the quarter ending December 31, 2001 include a gain on
the sale of the shares of $846 partially offset by pension expense of $7.
Industrial Segment - In fiscal 1989, SunLink discontinued the operations of its
industrial segment and subsequently disposed of substantially all related net
assets. However, obligations may remain relating to product liability claims for
products sold prior to the disposal. Noncurrent liabilities of discontinued
operations at December 31, 2002 and June 30, 2002 of $509 and $637,
respectively, relate to the industrial segment.

Noncurrent liabilities of discontinued operations at December 31, 2002 include
$1,088 relating to the housewares segment which represents a reserve for a
portion of a guarantee by a U.K. subsidiary of SunLink with respect to Beldray's
obligations under a lease covering a portion of Beldray's manufacturing
location. The guarantee runs through March 2019 and was made by the U.K.
subsidiary of SunLink for Beldray's lease obligation when Beldray was owned by
the subsidiary. The maximum potential obligation of SunLink under the guarantee
would be $8,367.


                                       8
<PAGE>

A currently inactive U.K. subsidiary of SunLink has an option to repurchase the
capital stock of Beldray for nominal consideration if any U.K. subsidiary of
SunLink is called upon to perform under the lease guarantee, or under certain
other conditions.

Over the past thirteen years SunLink has discontinued operations carried on by
its former industrial, U.K. leisure marine, life sciences and engineering, U.K.
child safety and U.K. housewares segments. Reserves for losses relating to
discontinued operations of these segments represent SunLink's best estimate of
the possible liability for property, product liability, and other claims for
which it may incur liability. These estimates are based on SunLink's judgments
using currently available information as well as, in certain instances,
consultation with its insurance carriers and legal counsel. SunLink historically
has purchased insurance policies to reduce certain of its product liability
exposure and may continue to purchase such insurance if available at
commercially reasonable rates. While SunLink has based its estimates on its
evaluation of available information, it is not possible to predict with
certainty the ultimate outcome of many contingencies relating to discontinued
operations. SunLink intends to adjust its estimates of the reserves as
additional information is developed and evaluated. Based on an evaluation of
information currently available and consultation with legal counsel, management
believes that the final resolution of these contingencies will not have a
material adverse impact on the financial position, cash flows, or results of
operations of SunLink.

NOTE 7. - RECENT ACCOUNTING PRONOUNCEMENTS

In June 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with
Exit or Disposal Activities. SFAS No. 146 requires the recording of costs
associated with exit or disposal activities at their fair values when a
liability has been incurred. Under previous guidance, certain exit costs were
accrued upon management's commitment to an exit plan, which is generally before
an actual liability has been incurred. SFAS No. 146 is to be applied
prospectively to exit or disposal activities initiated after December 31, 2002.

In November 2002, the FASB issued FASB Interpretation ("FIN") No. 45,
Guarantor's Accounting and Disclosure Requirements for Guarantees, including
Indirect Guarantees of Indebtedness of Others. FIN No. 45 elaborates on
disclosures to be made by a guarantor in its financial statements about its
obligations under certain guarantees that it has issued. It also clarifies that
a guarantor is required to recognize, at the inception of a guarantee, a
liability for the fair value of the obligation undertaken in issuing the
guarantee. The initial recognition and measurement provisions of FIN No. 45 are
applicable on a prospective basis to guarantees issued or modified after
December 31, 2002. The disclosure requirements in FIN No. 45 are effective for
all financial statements of periods ending after December 15, 2002. The
disclosures required by FIN No. 45 relating to the guarantee by a U.K.
subsidiary of SunLink of Beldray's obligations under a lease covering a portion
of Beldray's manufacturing location is included in Note 6. - Discontinued
Operations above.

In December 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based
Compensation - Transition and Disclosure- an amendment of FASB Statement No.
123. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based Compensation,
to provide alternative methods of transition for a voluntary change to the fair
value based method of accounting for stock-based employee compensation. In
addition, this Statement amends the disclosure requirements of SFAS No. 123 to
require prominent disclosures in both annual and interim financial statements
about the method of accounting for stock-based employee compensation and the
effect of the method used on reported results. This Statement requires new
disclosures about the effect of stock-based compensation on reported results and
also requires those effects be disclosed more prominently by specifying the
form, content and location of those disclosures. The transition guidance and
annual disclosure provisions of SFAS No. 148 are effective for fiscal years
ending after December 15, 2002. The interim disclosure provisions are effective
for financial reports


                                       9
<PAGE>

containing financial statements for interim periods beginning after December 15,
2002. The Company is currently assessing the impact of this new standard on its
consolidated financial statements.

NOTE 8. - LONG-TERM DEBT

<TABLE>
<CAPTION>
                                                   DECEMBER 31,      JUNE 30,
                                                       2002            2002
                                                   ------------    -----------
<S>                                                <C>             <C>
Senior subordinated note, net of
   unamortized discount of $2,106
   and $2,278                                        $ 17,435        $ 16,856
Senior subordinated zero coupon note,
   net of unamortized discount of $197
   and $339                                             1,453           1,661
Term loan                                               5,134           5,577
Other                                                     108             127
                                                     --------        --------
                                                       24,130          24,221
Less current maturities                                  (986)           (940)
                                                     --------        --------
                                                     $ 23,144        $ 23,281
                                                     ========        ========
</TABLE>

In connection with the acquisition of SunLink's six existing hospitals, SunLink
Healthcare Corp. ("SHC"), a wholly owned subsidiary of the Company, issued an
8.5% senior subordinated note in the face amount of $17,000 and a senior
subordinated zero coupon note in the face amount of $2,000, both to the seller.
The purchase agreement for the six hospitals included a provision for a
potential adjustment to the purchase price to the extent it was determined
working capital at the purchase date was greater or less than an agreed-upon
amount. In December 2002, SunLink and the seller agreed to a working capital
settlement that reduced the senior subordinated note by $350, extended the date
that interest payable on the senior subordinated note may be paid in additional
promissory notes to August 1, 2003, and reduced the senior subordinated zero
coupon by $350. The adjustments to the notes has been accounted for as a
reduction in the purchase price and has been allocated to reduce the basis of
long-lived assets acquired. A cumulative adjustment for interest expense
recorded for these two notes from February 1, 2001 to December 31, 2002 reduced
interest expense by $134 for the three and six months ended December 31, 2002.

The senior subordinated note is due on January 31, 2006 with interest payable
semiannually either in cash or additional promissory notes through August 1,
2003 and in cash thereafter. Additional promissory notes for $2,749 for interest
from February 1, 2001 through December 31, 2002 have been issued and the accrued
interest payable at December 31, 2002 of $142 is included in the senior
subordinated note. The stated interest rate of 8.5% on the senior subordinated
note was considered a below-market interest rate at the date of issuance,
therefore, the note was discounted to estimated market value at an effective
interest rate of 12.3%. The discount recorded on the senior subordinated note,
adjusted for the reduction in the principal amount in December 2002, was $2,873.

The senior subordinated zero coupon note is due January 31, 2004. The interest
rate on the senior subordinated zero coupon note was considered less than the
market rate at the date of issuance, therefore, the note was discounted to an
estimated market interest rate of 11.3%. The original issue discount on the
senior subordinated zero coupon note, adjusted for the reduction in the
principal amount in December 2002, was $490.

The discounts on the long-term debt were determined by SunLink in consultation
with its financial advisor based on high-yield debt instruments of similar
health care providers and are being amortized over the term of the related debts
instrument using the effective interest method. For the three months ended
December 31, 2002, SunLink recognized amortization expense on the


                                       10
<PAGE>

discounts of $156 and $145, respectively and for the six months ended December
31, 2002 and 2001, $328 and $283, respectively.

The loan agreement pursuant to which the senior subordinated note and the senior
subordinated zero coupon note were issued requires that SHC grant to the lender
a security interest in and mortgage on collateral consisting of SHC and its
subsidiaries' real and personal property, unless SHC has outstanding senior
indebtedness that meets certain conditions. The senior subordinated note and the
senior subordinated zero coupon note presently are not collateralized. Each of
the individual hospital subsidiaries of SHC is a guarantor of these notes.
Further, these notes are subordinate in payment and collateral to all defined
senior indebtedness of SHC which in the aggregate does not exceed $15,000, other
than debt incurred in connection with certain future acquisitions.

On January 4, 2002, SunLink entered into a $14,000 credit facility comprised of
a 36-month secured revolving line of credit for up to $8,000 with interest at
prime plus 1.25% and a $6,000 secured term loan repayable over 66 months at an
interest rate of 9.78%. The availability of borrowings under the revolving
credit facility is based upon, among other things, a borrowing base keyed to the
level of SHC receivables which, based upon the Company's estimates, provides
borrowing capacities of approximately $6,800 at December 31, 2002. The revolving
credit facility is secured by the patient accounts receivable of SHC. No amount
was outstanding on the revolving credit facility at December 31, 2002, however,
SunLink began drawing on the facility in January 2003. The net proceeds from the
term loan of $5,800 are being used for working capital and to fund a portion of
SunLink's hospital capital projects which include a new replacement hospital in
Jasper, Georgia, and a new emergency room at its hospital in Ellijay, Georgia.
The term loan is secured by liens on SHC's real and personal property, except
for patient accounts receivables, as well as the capital stock owned by SHC and
its subsidiaries. Also, each of the hospital subsidiaries is a guarantor of the
loan.

SunLink has funded the construction costs for the replacement for its
Mountainside Medical Center in Jasper, Georgia, from the term loan and internal
funds. The replacement facility is currently under construction and is currently
scheduled to open in May 2003. On September 30, 2002, SunLink entered into a
$6,000 secured bank financing facility (the "Mountainside Financing Facility")
to provide completion financing for the replacement hospital. Under the
Mountainside Financing Facility , SunLink may borrow up to $6,000 under a
construction loan with interest at prime plus 1% per annum. At December 31,
2002, SunLink had not borrowed under the Mountainside Financing Facility but
continued to fund constructions under availability under its revolving credit
agreement. SunLink expects funding under the construction loan to commence
during its third fiscal quarter ending March 31, 2003.

Under the Mountainside Financing Facility, the construction loan may be
converted to a 20-year mortgage loan three months after completion of
construction, subject to certain conditions. The 20-year mortgage loan option
would bear interest at prime plus 1% per annum or, at SunLink's option, interest
at the 5-year U.S. Treasury Constant Maturity Yield plus 3 1/2%. The actual
mortgage loan interest rate is adjustable every 5 years. The Mountainside
Financing Facility requires SunLink to comply with certain conditions and
covenants including hospital financial and operational covenants, information
requirements and limitations on secured debt by the hospital subsidiary.

NOTE 9.  - INCOME TAXES

Income tax expense $67 was recorded for the three months ended December 31,
2002, resulting from $18 federal tax expense and $49 state tax expense. For the
six months ended December 31, 2002, income tax expense of $159 was recorded
resulting from $68 federal tax expense and $91 state tax expense. SunLink had a
federal net operating loss carryforward of approximately $6,400


                                       11
<PAGE>

at December 31, 2002. Use of this net operating loss carryforward is subject to
the limitations of the provisions of Internal Revenue Code Section 382. As a
result, not all of the net operating loss carryforward is useable to offset
federal taxable income in the current year. SunLink has provided a valuation
allowance for the entire amount of the deferred tax assets (the majority of
which is the federal net operating loss carryforward) as it is management's
assessment based upon the criteria identified in SFAS No. 109, that it is
currently more likely than not that none of the deferred tax asset will be
realized through future taxable earnings or implementation of tax planning
strategies. No income tax expense was provided in the three and six months ended
December 31, 2001 due to the loss before tax for such prior periods.

NOTE 10. -- COMPREHENSIVE EARNINGS (LOSS)

Comprehensive earnings (loss) for SunLink includes foreign currency translation
adjustments. Total comprehensive earnings (loss) for the following periods was
as follows:

<TABLE>
<CAPTION>
                                              THREE MONTHS ENDED
                                         ----------------------------
                                         DECEMBER 31,     DECEMBER 31,
                                             2002            2001
                                         ------------     ------------
<S>                                      <C>              <C>
Net earnings (loss):                       $  (986)          $ 781
Other comprehensive
 Income net of tax:
   Change in equity due to:
      Foreign currency
          translation adjustments              (25)            (31)
                                           -------           -----
Comprehensive earnings (loss)              $(1,011)          $ 750
                                           =======           =====
</TABLE>



<TABLE>
<CAPTION>
                                                SIX MONTHS ENDED
                                         ----------------------------
                                         DECEMBER 31,     DECEMBER 31,
                                             2002            2001
                                         ------------     ------------
<S>                                      <C>              <C>
Net earnings (loss):                       $(551)          $ 435
Other comprehensive
 Income net of tax:
   Change in equity due to:
      Foreign currency
          Translation adjustments            (47)           (150)
                                           -----           -----
Comprehensive earnings (loss)              $(598)          $ 285
                                           =====           =====
</TABLE>


NOTE 11. -  COMMITMENTS AND CONTINGENCIES

As discussed in Note 6. - "Discontinued Operations", a U.K. subsidiary of
SunLink remains contingently liable as guarantor of Beldray's obligations under
a lease covering a portion of Beldray's manufacturing location.

Reserves relating to discontinued operations represent management's best
estimates of possible liability for the contingent liabilities of discontinued
operations. While SunLink has based its estimates on its evaluation of available
information, it is not possible to predict with certainty the ultimate outcome
of many contingencies relating to discontinued operations. SunLink intends to
adjust its estimates of the reserves as additional information is developed and
evaluated. Based


                                       12
<PAGE>

on an evaluation of information currently available and consultation with legal
counsel, management believes that the final resolution of these contingencies
will not have a material adverse impact on the financial position, cash flows or
results of operations of SunLink.

As of December 31, 2002, SunLink had future commitments for capital expenditures
of approximately $8,850 relating to the new Jasper, Georgia hospital and of
approximately $900 for the new emergency room at the North Georgia Medical
Center in Ellijay, Georgia,. Subject to internal approval of specific capital
items and the availability of funds, SunLink expects to spend approximately
$1,050 in additional capital expenditures during the remaining six months of the
fiscal year ended June 30, 2003, primarily for new and replacement equipment.

SunLink is a party to claims and litigation incidental to its business, as to
which it is not currently possible to determine the ultimate liability, if any.
Based on an evaluation of information currently available and consultation with
legal counsel, management believes that resolution of such claims and litigation
is not likely to have a material effect on the financial position, cash flows,
or results of operations of SunLink.

Contractual obligations related to long-term debt, noncancellable operating
leases and physician guarantees at December 31, 2002 were as follows:


CONTRACTUAL OBLIGATIONS

<TABLE>
<CAPTION>
Payments                     Long-Term        Operating       Physician
due in:                         Debt            Leases       Guarantees
                            ---------        ----------     ------------
<S>                         <C>              <C>            <C>
   1 year                   $     986        $    2,186     $      1,930
   2 years                      2,536             1,685              741
   3 years                      1,191               936              300
   4 years                     18,729               286              175
   5 years                        688                40
   More than 5 years               --             3,303
                            ---------        ----------     ------------
                            $  24,130        $    8,436     $      3,146
                            =========        ==========     ============
</TABLE>


At December 31, 2002, SunLink had contracts with 15 physicians which contain
guaranteed minimum gross receipts. If a physician's gross receipts are less than
a specific yearly amount, then the difference is paid by SunLink to the
physician. SunLink's policy is to expense physician guarantees as payments are
made on such guarantees and during the three and six months ended December 31,
2002 expensed $402 and $957, respectively, of physician guarantees.


                                       13
<PAGE>


            ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                      CONDITION AND RESULTS OF OPERATIONS
          (DOLLARS IN THOUSANDS, EXCEPT PER SHARE AND ADMISSIONS DATA)

RECENT DEVELOPMENTS

         On October 15, 2002, SunLink announced that it and a wholly owned
subsidiary of SunLink had signed a definitive merger agreement to acquire all of
the outstanding capital stock of HealthMont, Inc. ("HealthMont"), a privately
held operator of community hospitals. If the transaction is consummated, SunLink
would acquire two community hospitals: Memorial Hospital of Adel, a 60-bed
acute-care facility in Adel, Georgia, which includes a 95-bed nursing home, and
Callaway Community Hospital, a 49-bed acute-care hospital in Fulton, Missouri.
HealthMont currently operates another community hospital in San Benito, Texas,
which is to be sold prior to the completion of the merger. Upon completion of
the merger, the Company would operate eight community hospitals with a total of
442 beds.

         Under the terms of the merger agreement, SunLink would, among other
things, issue to the shareholders of HealthMont up to 1,155,000 common shares of
SunLink in consideration for all issued and outstanding capital stock of
HealthMont. HealthMont currently has approximately 120 shareholders and
approximately 6,248,000 HealthMont shares are expected to be outstanding
immediately prior to closing. Accordingly, each HealthMont shareholder is
expected to receive one common share of SunLink for each 5.4083 HealthMont
shares (approximately 0.1849 of a common share of SunLink for each share of
HealthMont).

         In addition, SunLink would issue 95,000 common shares in connection
with the transaction to settle certain contractual obligations of HealthMont to
its officers and directors. SunLink would also become obligated to issue
approximately 20,000 common shares upon exercise of outstanding HealthMont
options.

         In connection with the transaction, SunLink currently would assume up
to a total of $9,800 (consisting of a senior credit facility of approximately
$8,900 and capital leases, primarily for equipment, of approximately $900) in
HealthMont debt and enter into a $3,000, 3-year term loan which will be used for
the repayment of $600 of HealthMont's senior debt at closing, payment of certain
transaction costs and for working capital. The working capital loan will bear
interest at 15% per annum and will require SunLink to pay certain fees. SunLink
will also issue warrants to purchase 75,000 of its common shares at an exercise
price of $0.01 per share.

         Subject to a number of conditions, HealthMont obtained the consent of
its senior lender to the proposed merger of HealthMont by SunLink and the
modification of certain terms of HealthMont's senior debt, including the
principal repayment of $600 at the closing of the merger and an extension of the
maturity date of the remaining debt to August 31, 2005. Post merger, the
remaining senior debt is expected to be comprised of term loans of approximately
$5,000 with interest at prime plus 2% per annum and revolving credit loans of
approximately $3,900 with interest at prime plus 1 1/2%. Upon completion of the
merger, HealthMont's senior lender would receive warrants to purchase 27,000
shares of SunLink's common shares at an exercise price of $0.01 per share.
Certain HealthMont investors have arranged letters of credit which support up to
$1,650 of HealthMont's revolving credit loans. Subject to completion of the
merger, SunLink has agreed, in the event the letters of credit are drawn and the
proceeds are used to reduce the outstanding balance of the revolving credit
loans, to issue to those such letter of creditor obligors 350,000 of SunLink's
common shares in full satisfaction of HealthMont's reimbursement obligations
under the letters of credit. SunLink would also pay to such letter of credit
obligors a 5% commitment fee annually through August 31, 2005 in consideration
of their obligations to maintain the letters of credit.


                                       14
<PAGE>

         Based on the average market price of SunLink's common shares two days
before, the day of and two days after the merger agreement was entered into, of
$2.41 per share, plus the amount of senior debt and capital lease obligations to
be assumed, and plus currently estimated transaction costs, the price to SunLink
of the transaction will be approximately $14,700.

         Subject to certain conditions, the merger agreement provides that it is
cancelable by either party if not completed by January 31, 2003. On January 28,
2003, SunLink notified HealthMont of its position that, as a result of delays
attributable to preparation of the HealthMont financial information for the
merger Proxy/Registration statement, HealthMont does not have the ability to
terminate the merger agreement without cause. HealthMont has disagreed with
SunLink's position but has not notified SunLink it intends to cancel the merger
agreement.

         On January 29, 2003, SunLink filed its preliminary Proxy/Registration
on Form S-4 with the Securities and Exchange Commission and preliminarily
scheduled a special shareholders' meeting for March 27, 2003 to vote on the
proposed merger.

         On January 30, 2003, SunLink received a letter from HealthMont
purporting to conclude that an merger proposal HealthMont received from a third
party was a superior proposal within the terms of the merger agreement. SunLink
believes the valuation ascribed to the competing proposal was flawed in several
material respects and is evaluating the information provided by HealthMont.
Accordingly, SunLink has not determined that HealthMont has, in fact, received a
superior proposal.

         Although the merger agreement remains in full force and effect,
capitalized costs of $411 relating to the merger through December 31, 2002 have
been expensed during the quarter ended December 31, 2002 because SunLink
currently can no longer determine that it is probable that the HealthMont merger
will be completed. SunLink anticipates additional expenses related to the
proposed merger of HealthMont that were incurred subsequent to December 31, 2002
of approximately $200 will be expensed during the quarter ended March 31, 2003.

         SunLink and HealthMont have engaged in discussions concerning possible
amendments to the merger agreement, as well as possible financial support of
HealthMont by SunLink to enable HealthMont to continue its current operations
until the merger can be completed. No specific additional agreements or
modifications to the merger agreement have been reached and no assurances can be
given that any additional agreements or any modifications to the merger
agreement will be reached, or that the merger will be completed. Completion of
the merger is subject to a number of conditions, including regulatory approvals,
approval of the transaction by the shareholders of both SunLink and HealthMont
and modification of the terms of HealthMont's existing senior debt or
availability to SunLink of alternative financing.

         The unaudited net revenues of the two HealthMont facilities to be
acquired through the merger were approximately $28,200, as reported by
HealthMont for the twelve months ended March 31, 2002. SunLink does not plan to
add any corporate staff or to significantly increase its overhead as a result of
the merger. SunLink will not acquire HealthMont's corporate staff and facilities
in connection with the merger.


                                       15
<PAGE>



FINANCIAL SUMMARY

<TABLE>
<CAPTION>
                                         THREE MONTHS ENDED          SIX MONTHS ENDED
                                           DECEMBER 31,                 DECEMBER 31,
                                      ----------------------      ----------------------
                                        2002          2001          2002          2001
                                      --------      --------      --------      --------
<S>                                   <C>           <C>           <C>           <C>
Net revenues                          $ 23,675      $ 21,590      $ 47,476      $ 43,139
Operating expenses (1)                 (22,418)      (20,856)      (44,588)      (42,033)
                                      --------      --------      --------      --------
EBITDA (2)                               1,257           734         2,888         1,106
Depreciation and amortization             (362)         (329)         (718)         (617)
Asset impairment charge                 (1,562)           --        (1,562)           --
Gain on sale of property & equip            --           310            --           329
                                      --------      --------      --------      --------
                                          (667)          715           608           818
Interest expense                          (592)         (694)       (1,341)       (1,403)
Interest income                             24             5            40            19
                                      --------      --------      --------      --------
Earnings (Loss) from Continuing
   Operations Before Income Taxes     $ (1,235)     $     26      $   (693)     $   (566)
                                      ========      ========      ========      ========

Equivalent Admissions                    4,433         3,927         9,095         7,994
                                      ========      ========      ========      ========

Revenue per Equivalent Admissions     $  5,340      $  5,498      $  5,220      $  5,396
                                      ========      ========      ========      ========
</TABLE>


(1)      Operating expenses include salaries and benefits, provision for bad
         debts, supplies, purchased services, rent and operating expenses, and
         exclude the items that are excluded for purposes of determining EBITDA
         as discussed in footnote (2) below.

(2)      EBITDA consists of income (loss) before interest,
         income taxes, depreciation and amortization, gain on sale of property
         and equipment and the asset impairment charge. EBITDA should not be
         considered a measure of financial performance under generally accepted
         accounting principles ("GAAP"). EBITDA is a key measure used by
         SunLink to evaluate our operations and provide useful information to
         investors. EBIDTA should not be used in isolation or as an alternative
         to net income, cash flows generated by operations, investing or
         financing activities, or other financial statement data presented in
         the consolidated condensed financial statements as indicators of
         financial performance or liquidity. Because EBITDA is not a
         measurement determined in accordance with GAAP and is thus susceptible
         to varying calculations, EBITDA as presented may not be comparable to
         other similarly titled measures of other companies. EBITDA information
         is included because SunLink believes such information is of interest to
         the investment community. Such information provides an additional
         method of evaluating SunLink's performance from period to period.
         SunLink believes the investment community often views EBITDA as a
         useful performance measurement in a capital intensive business such
         as community hospitals.


RESULTS OF OPERATIONS

         All of our net revenues are from our U.S. community hospital segment
which was acquired February 1, 2001. The operations of our former U.K.
housewares business segment, which was disposed of on October 5, 2001, are
reported in discontinued operations for the three and six months ended December
31, 2001.

         Net revenues for the quarter ended December 31, 2002 were $23,675 with
a total of 4,433 equivalent admissions and revenues per equivalent admission of
$5,340 compared to net revenues of $21,590, a total of 3,927 equivalent
admissions and revenues per equivalent admission of $5,498 for the quarter ended
December 31, 2001. The 9.7% increase in net revenues for the quarter December
31, 2002 was due to the 12.9% increase in equivalent admissions and $898 for
settlements and filings of prior year Medicare and Medicaid cost reports. Also
recorded in the quarter ended December 31, 2002 as a reduction from net revenue

                                       16
<PAGE>

was a $383 payment in settlement of a Medicaid indigent care issue. The increase
in net revenues of 9.7% was less than the 12.9 % increase in equivalent
admissions. This was due to an increase in net out-patient service revenue from
46.7% in the prior year's quarter to 47.4% in the current year's quarter. Total
surgeries increased 27.8% in the quarter ended December 31, 2002 compared to the
same quarter last year.

         Net revenues for the six months ended December 31, 2002 were $47,476,
with a total of 9,095 equivalent admissions and revenues per equivalent
admission of $5,220 compared to net revenues of $43,139, a total of 7,994
equivalent admissions and revenues per equivalent admissions of $5,396 for the
six months ended December 31, 2001. The 10.1% increase in net revenues in the
current year was due to the 13.8% increase in equivalent admissions and $898 for
the settlements and filings of prior year Medicare and Medicaid cost reports.
Net revenues decreased by $383 during the six months ended December 31, 2002 for
a payment in settlement of a Medicaid indigent care issue. The 10.1% increase in
net revenues was less than the 13.8% increase in equivalent admissions. This
results from an increase in net out-patient service revenue from 48.1% in the
six months ended December 31, 2001 to 48.9% in the current year for the same six
month period. Total surgeries increased 18.0% in the six months ended December
31, 2002 compared to the same period last year. We added 13 net new doctors
during the year ended June 30, 2002 and 11 net new doctors during the six months
ended December 31, 2002. We also have expended approximately $5,000 for capital
expenditures to upgrade services and facilities since the acquisition on
February 1, 2001. We believe the upgraded services and facilities and the new
doctors contributed to the 10.0% increase in net revenues for the six months
ended December 31, 2002 compared to the same period last year. We continue to
seek increased equivalent admissions by attracting additional physicians to our
hospitals, further upgrading the services offered by the hospitals and improving
the hospitals' physical facilities.

         The source of the increase in the net revenues for the first six months
of our fiscal year was primarily Medicare and Medicaid patients while net
revenues from commercial and private patients were relatively unchanged. Net
outpatient service revenues for the quarter ended December 31, 2002 were $11,218
or 47.4% of total net revenues for the quarter, an increase of 11.4% from the
quarter ended December 31, 2001 which included net outpatient service revenues
of $10,071 or 46.7% for that quarter of total net revenues. For the six months
ended December 31, 2002, net outpatient service revenues were $23,220 or 48.9%
of total net revenues for the period compared to $20,745 or 48.1% for the same
period last year.

         The following table sets forth the percentage of net patient revenues
from various payors in the Company's hospitals for the periods indicated:

<TABLE>
<CAPTION>
                                 Three months Ended December 31,
                                 -------------------------------
                                    2002                  2001
                                   ------                ------
<S>                              <C>                     <C>
SOURCE
Medicare                             47.6%                 47.4%
Medicaid                             14.8%                 13.6%
Self pay                              7.5%                  8.4%
Private and others                   30.1%                 30.6%
                                   ------                ------
                                    100.0%                100.0%
                                   ======                ======
</TABLE>


                                       17
<PAGE>


<TABLE>
<CAPTION>
                                  Six months Ended December 31,
                                  -----------------------------
                                    2002                  2001
                                   ------                ------
<S>                               <C>                    <C>
SOURCE
Medicare                             48.0%                 46.9%
Medicaid                             14.4%                 13.0%
Self pay                              7.7%                  8.4%
Private and others                   29.9%                 31.7%
                                   ------                ------
                                    100.0%                100.0%
                                   ======                ======
</TABLE>

         Operating expenses, including depreciation and excluding the asset
impairment charge of $1,562, were $22,780 and $21,185 for the quarters ended
December 31, 2002 and 2001, respectively and $45,306 and $42,650 for the six
months ended December 31, 2002 and 2001, respectively.

<TABLE>
<CAPTION>
                                         Operating Expenses as % of Net Revenues
                                             Three Months Ended December 31,
                                             -------------------------------
                                               2002                  2001
                                             ------                 ------
<S>                                      <C>                        <C>
Salaries, wages and benefits                   47.6%                 49.6%
Provision for bad debts                        10.7%                 11.9%
Supplies                                       11.6%                 10.8%
Purchased services                              7.8%                  8.6%
Other operating expenses                       13.0%                 13.2%
Rent and lease expense                          2.3%                  2.5%
</TABLE>

<TABLE>
<CAPTION>
                                        Operating Expenses as % of Net Revenues
                                              Six Months Ended December 31,
                                              -----------------------------

                                               2002                  2001
                                              ------                ------
<S>                                     <C>                         <C>
Salaries, wages and benefits                   46.7%                 49.8%
Provision for bad debts                        11.2%                 12.5%
Supplies                                       11.5%                 11.0%
Purchased services                              7.9%                  8.3%
Other operating expenses                       13.5%                 13.2%
Rent and lease expense                          2.3%                  2.4%
</TABLE>


         Most operating expense categories decreased as a percentage of net
revenues in the current year due to the increased net revenues and efforts to
control costs in the hospitals. Salaries, wages and benefits expense decreased
as a percentage of net revenues for the current quarter due to cost control
initiatives undertaken in each facility to reduce labor costs. The provision for
bad debts was 10.7% of net revenues in the quarter ended December 31, 2002, a
decrease of 1.2% of net revenues from the prior year due to improved
collections, decreased self-pay net revenues and increased Medicare and Medicaid
net revenues as a percentage of total net revenues. Improved collections were
facilitated by the hospitals implementing additional business office systems and
procedures designed to minimize bad debts. Supplies expense increased slightly
as a percentage of net revenues in the current year due to the 27.8% increase in
total surgeries for the three months and 18.0% increase in total surgeries for
the six months. The increase in other operating expenses as a percent of net
revenue in the current year reflects increased physician guarantee expense in
the current year resulting from the 24 net new


                                       18
<PAGE>

physicians recruited during the 18 months prior to December 31, 2002 and
increased insurance expense. Insurance expense is expected to continue to
increase during this fiscal year and next.

         SunLink expensed previously capitalized costs through December 31, 2002
of $411 relating to the possible merger with HealthMont. Such costs were
expensed because SunLink can no longer determine that it is probable that the
HealthMont merger will be completed. We expect to expense additional expenses of
the proposed merger incurred subsequent to December 31, 2002 of approximately
$200 during the quarter ended March 31, 2003 unless we can determine that the
transaction is again probable. Unless we can determine that the transaction is
again probable, future expenses related to the possible merger will be expensed
in the quarter in which they are incurred.

         The Company is currently building a new hospital in Jasper, Georgia,
which will replace its existing Mountainside Medical Center hospital. The new
hospital is scheduled to begin operations in May 2003. During the quarter ended
December 31, 2002, SunLink determined that the carrying value of the
Mountainside Medical Center hospital and an adjacent medical office building
exceeded their estimated fair value by $1,482 and $80, respectively. An
impairment loss of $1,562 was recorded to write down the hospital and medical
office building to fair value based on outside appraisals. After the new
hospital begins operations, it is anticipated that the medical office building
will be retained and continue to be leased to medical practitioners but the old
hospital will be held for sale.

         Interest expense was $592 and $694 for the three months ended December
31, 2002 and 2001, respectively and $1,341 and $1,403 for the six months ended
December 31, 2002, respectively. The decrease in the current year was due to an
adjustment of $134 to decrease interest expense as a result of the reduction of
the principal amounts of the senior subordinated note and the senior
subordinated zero coupon note in December 2002. The two notes were issued in
connection with the acquisition of SunLink's six existing hospitals in February
2001. In December 2002, settlement of working capital purchased with the
acquisition resulted in the reduction of the principal of the two notes
retroactive to February 2001, which resulted in the $134 decrease to interest
expense. Cash interest paid during the six months ended December 31, 2002 was
$264, including $216 of interest capitalized in property, plant and equipment.

         We recorded an income tax expense of $67 ($18 federal tax and $49 state
tax) for the three months ended December 31, 2002. For the six months ended
December 31, 2002, we recorded income tax expense of $159 ($68 federal tax and
$91 for state tax). For the three and six months ended December 31, 2002, a gain
from discontinued operations of $331 relating to a domestic capital loss tax
carry-back was reported as a gain on the disposal of our former housewares
segment. This capital loss carry-back resulted from carrying-back capital losses
on SunLink's investment in Beldray against capital gains of earlier years. We
had a net operating loss carryforward for federal income tax purposes of
approximately $6,400 at December 31, 2002. Use of this net operating loss
carryforward is subject to the limitations of the provisions of Internal Revenue
Code Section 382. As a result, not all of the net operating loss carryforward is
useable to offset federal taxable income in the current year and federal income
tax expense results. We have provided a valuation allowance for the entire
amount of our deferred tax assets (the majority of which is the net operating
loss carryforward for federal income tax purposes) as it is our assessment based
upon the criteria identified in SFAS No. 109 that it is currently more likely
than not that none of the deferred tax assets will be realized through future
taxable earnings or implementation of tax planning strategies. We recorded no
income tax expense in the three and six months ended December 31, 2001 due to
the loss before tax for such prior periods.

         Our loss from continuing operations was $1,302 ($0.26 per share) in the
quarter ended December 31, 2002 compared to earnings from continuing operations
of $26 ($0.01 share) in the comparable quarter last year. The current year loss
from continuing operations resulted from the


                                       19
<PAGE>

$1,562 asset impairment charge and the expensing of $411 of costs related to the
HealthMont merger. EBITDA for the three months ended December 31, 2002 of $1,257
compared to $734 for the same period of last fiscal year. The increase in the
current year resulted from the increased net revenues and cost controls.
Included in earnings from continuing operations for the three months ended
December 31, 2001 was a $310 gain on sale of property and equipment.

         The loss from continuing operations of $852 for the six months ending
December 31, 2002 ($0.17 per share) compared to a loss from continuing
operations of $566 ($0.11) last year. EBITDA for the six months ended December
31, 2002 of $2,888 compared to $1,106 for the same period of last fiscal year.
The current year loss from continuing operations resulted from the $1,562 asset
impairment charge and the expensing of $411 of costs related to the HealthMont
merger.

         The net loss of $986 ($0.20 per share) for the three months ended
December 31, 2002 includes $331 of earnings from discontinued operations
resulting from a domestic capital loss tax carry-back compares to net earnings
of $781 for the three months ended December 31, 2001, which includes earnings of
discontinued operations of $755. The net loss for the six months ended December
31, 2002 of $551 ($0.11 per share) compares to net earnings of $435 ($0.09) for
the prior year six months.

LIQUIDITY AND CAPITAL RESOURCES

         We generated $1,017 of cash from operating activities during the six
months ended December 31, 2002 compared to $985 generated during the comparable
period last year. The cash generated in the current year resulted primarily from
cash generated from the non-cash asset impairment charge of $1,562, non-cash
depreciation expense of $718 and non-cash interest expense of $1,077 offset by
cash usage of the net loss of $551, cash used by working capital of $1,525 and
the cash interest paid of $264. A portion of the increase in accounts payable
for the six months ended December 31, 2002 that relates to construction costs of
$2,396 are not included in cash flows from operations because it relates to cash
flows from investing activities. Increased accounts receivable and other current
assets and decreased current liabilities, primarily accounts payable and
third-party payor settlements, generated a use of cash for the six month period.

         We expended $5,806 for capital improvements at our hospitals during the
six months ended December 31, 2002. This excludes $2,396 included in accounts
payable at December 31, 2002 and subsequently paid in January 2003. In addition
to routine capital expenditures of $1,293 during the six months, primarily for
new and replacement equipment, we expended $3,676 for the replacement hospital
in Jasper, Georgia and $837 for a new emergency room at North Georgia Medical
Center in Ellijay, Georgia. We believe an attractive physical facility assists
in recruiting quality staff and physicians, as well as attracting patients.
Subject to availability of internally generated funds committed and other
financing, we expect to expend approximately $10,800 for capital expenditures
during the remaining six months of the fiscal year ending June 30, 2003,
approximately $8,850 of which will be used for the replacement hospital in
Jasper, Georgia and approximately $900 will be used for the new emergency room
in Ellijay, Georgia. The total estimated cost of the new Jasper hospital is
approximately $15,800, of which approximately $6,950 had been expended as of
December 31, 2002. We expect to fund our planned capital expenditures through
borrowing under a $6,000 financing facility for the replacement hospital for our
existing Mountainside Medical Center, through borrowings under our $8,000
revolving line of credit and with cash generated from continuing operations.

         Our primary sources of liquidity are cash from continuing operations
and borrowing under our credit facilities. Historically, our primary sources of
liquidity have included our existing sources as well as borrowings under a term
loan entered into at the same time as our revolving line of credit. Our credit
facilities include an $8,000 secured revolving line of credit


                                       20
<PAGE>

which matures December 31, 2004 and a $6,000 secured bank financing facility for
the construction of the Jasper replacement hospital. The net proceeds from the
term loan in the amount of $5,800 have been used for working capital and to fund
a portion of the hospital capital projects which include a replacement hospital
in Jasper, Georgia, and a new emergency room in Ellijay, Georgia. At December
31, 2002, the term loan balance was $5,134.

         The availability of borrowing under the revolving line of credit is
based upon, among other things, a borrowing base keyed to the level of the
hospital's receivables. Based upon SunLink's estimates, the secured revolving
line of credit provided borrowing capacity of approximately $6,800 at December
31, 2002. No amount was borrowed on the revolving line of credit at December 31,
2002, however SunLink began using the line in January 2003. If the amount or
quality of receivables is lower than expected, our borrowing capacity under the
secured revolving line of credit will also be lower. If SunLink experiences a
material adverse change in its businesses, assets, financial condition,
management or operations, or the value of the collateral securing the credit
facility, we may be unable to draw on the revolving line of credit.

         SunLink has funded the construction costs for the replacement hospital
for its Mountainside Medical Center in Jasper, Georgia under from the term loan
and internal funds. The replacement hospital is under construction and scheduled
to open in May 2003. On September 30, 2002, SunLink entered into a $6,000
secured bank financing facility ("the Mountainside Financing Facility") to
provide an alternate means of financing the replacement hospital. Under the
Mountainside Financing Facility, SunLink may borrow up to $6,000 under a
construction loan with interest at prime plus 1% per annum. At December 31,
2002, SunLink had not borrowed under the Mountainside Financing Facility, but
continued to fund construction costs its revolving credit agreement. SunLink
expects funding under the construction loan to commence during its third fiscal
quarter ending March 31, 2003.

         Under the Mountainside Financing Facility, the construction may be
converted to a 20-year mortgage loan three months after the completion of
construction, subject to certain conditions. The 20-year mortgage loan option
would bear interest at prime plus 1% per annum or, at SunLink's option, interest
at the 5-year U.S. Treasury Constant Maturity Yield plus 3 1/2%. The actual
mortgage loan interest rate is adjustable every 5 years. The Mountainside
Financing Facility requires SunLink to comply with certain conditions and
covenants including hospital financial and operational covenants, information
requirements and limitations on secured debt by the hospital subsidiary which
owns and operates the Jasper, Georgia hospital.

         The debt capacity of our subsidiary, SunLink Healthcare Corp. ("SHC"),
which holds the stock of our existing six-hospital subsidiaries, is limited and
is subject to certain leverage tests by its loan agreements. Under the most
limiting of such tests, SHC would, at December 31, 2002, have been able to incur
up to approximately $9,900 of additional indebtedness. This does not include any
amount relating to the proposed HealthMont merger which is not currently
expected to involve SHC.

         Contractual obligations related to long-term debt, noncancellable
operating leases and physician guarantees at December 31, 2002 were as follows:


CONTRACTUAL OBLIGATIONS

<TABLE>
<CAPTION>
Payments                   Long-Term       Operating        Physician
due in:                      Debt           Leases         Guarantees
                           ---------       ---------       ----------
<S>                        <C>             <C>             <C>
1 year                     $   986          $2,186          $1,930
2 years                      2,536           1,685             741
3 years                      1,191             936             300
4 years                     18,729             286             175
5 years                        688              40
More than 5 years               --           3,303
                           -------          ------          ------
                           $24,130          $8,436          $3,146
                           =======          ======          ======
</TABLE>


                                       21
<PAGE>


         At December 31, 2002, SunLink had contracts with 15 physicians which
contain guaranteed minimum gross receipts. If a physician's gross receipts are
less than a specific yearly amount, then the difference is paid by SunLink to
the physician. SunLink's policy is to expense physician guarantees as payments
are made on such guarantees and during the three and six months ended December
31, 2002 expensed $402 and $957, respectively, of physician guarantees.

         At December 31, 2002, we had outstanding long-term debt of $24,130, of
which $18,888 was incurred in connection with our purchase on February 1, 2001
of our six existing community hospitals and related businesses, $5,134 was
outstanding under the term loan, and $108 related to capital leases. At such
date, our debt included a seller financed balloon note of $17,435 and a seller
financed zero coupon note of $1,453. The purchase agreement for the six
hospitals provided for an adjustment to the balloon and zero-coupon notes to the
extent working capital at the purchase date was greater or less than an agreed
upon amount. In December 2002, SunLink and the seller agreed to a working
capital settlement that reduced the balloon note by $350, extended to August 1,
2003 the date that interest payable on the balloon note may be paid in PIK notes
and reduced the zero coupon note by $350. The balloon note, due January 31,
2006, has a face amount of $16,650 and a stated interest rate of 8.5% which,
because it was considered a below market interest rate at the date of issuance,
has been discounted for financial reporting purposes to a market interest rate
of 12.3%. As noted above , the balloon note has a payment-in-kind (PIK) feature
for interest accrued through August 1, 2003. Interest due and payable through
that date may be paid in additional balloon notes due in 2006 and we presently
intend to issue PIK notes for interest due through August 1, 2003. Additional
promissory notes have been issued for interest payable from February 1, 2001 to
November 30, 2002 totaling $2,749 and the interest accrued through December 31,
2002 of $142 has been included in the principal amount of the balloon note at
December 31, 2002. The zero coupon note is due January 31, 2004, has a face
amount of $1,650, and has been discounted to a market interest rate of 11.3%.
The principal amount of the zero coupon note is subject to reduction for certain
indemnified items pursuant to the purchase agreement.

         Our contingent obligations, other than with respect to our existing
operations, include potential product liability claims for products manufactured
and sold before the disposal of our discontinued industrial segment in fiscal
1989, and for guarantees of certain obligations of former non-U.S. subsidiaries.
We have provided an accrual at December 31, 2002 related to a portion of the
guarantee by one of our U.K. subsidiaries of a lease covering a portion of a
manufacturing facility utilized by our former U.K. housewares operations. We are
currently in the process of liquidating two dormant subsidiaries in Germany and
France. Based upon an evaluation of information currently available and
consultation with legal counsel, management has not reserved any amounts for
contingencies related to these liquidations.

         We believe we have adequate financing and liquidity to support our
current level of operations through the next twelve months. As noted above, our
current sources of liquidity are our $8,000 revolving credit facility, our
$6,000 Mountainside Financing Facility related to the hospital being constructed
in Jasper, Georgia and cash generated from our community hospital operations.
Availability under the revolving credit facility is based upon the level of our
receivables. The current availability at December 31, 2002 of approximately
$6,800 could be adversely affected by, among other things, decreases in
receivables due to lower demand for our services by patients, change in patient
mix and changes in terms and levels of government and


                                       22
<PAGE>

private reimbursement for services. Cash generated from operations could be
adversely affected by, among other things, lower patient demand for our
services, higher operating costs (including, but not limited to, salaries, wages
and benefits, provisions for bad debts, general liability and other insurance
costs, cost of pharmaceutical drugs and other operating expenses), or by changes
in terms and levels of government and private reimbursement for services and the
regulatory environment of the community hospital segment.

IMPACT OF POTENTIAL MERGER OF HEALTHMONT ON LIQUIDITY AND CAPITAL RESOURCES

         If we complete the proposed merger of HealthMont, we expect to assume
approximately $9,800 in HealthMont senior debt consisting of a senior credit
facility of approximately $8,900 and capital leases, primarily for equipment, of
approximately $900. Subject to a number of conditions, HealthMont has obtained
the consent of its senior lender to our proposed merger of HealthMont and the
modification of certain terms of HealthMont's senior credit facility, which
include a principal repayment of $600 at the closing of the merger and an
extension of the maturity date of the remaining debt to August 31, 2005. Post
merger, the remaining senior credit facility is expected to be comprised of term
loans of approximately $5,000 with interest at prime plus 2% per annum and
revolving credit loans of approximately $3,900 with interest at prime plus
1 1/2%.

         Certain HealthMont investors have arranged letters of credit which
support up to $1,650 of HealthMont's revolving credit loans. Subject to
completion of the merger, we have agreed that if the merger is completed and, in
the event the letters of credit are drawn and the proceeds are used to reduce
the outstanding balance of the revolving credit loans, to issue to such letter
of credit obligors up to 350,000 of the SunLink common shares in full
satisfaction of HealthMont's reimbursement obligations under the letters of
credit.

         In connection with the proposed merger of HealthMont, we will enter
into a $3,000, 3-year, secured term loan with a private lender. The proceeds of
such loan will be used primarily for working capital, including to repay $600 of
HealthMont's senior debt at closing and to pay certain transaction costs. The
loan will bear interest at 15% per annum and requires SunLink to pay certain
fees and issue warrants to the lender to purchase 75,000 SunLink common shares
at $0.01 per share.

CERTAIN CAUTIONARY STATEMENTS

         In addition to historical information, Items 1 and 2 of this report
contain certain forward-looking statements within the meaning of the safe harbor
for forward-looking statements contained in the Private Securities Litigation
Reform Act of 1995. Forward-looking statements include all statements that do
not relate solely to historical or current facts, and can be identified by the
use of words such as "may," "believe," "will," "expect," "project," "estimate,"
"anticipate," "plan," or "continue." These forward-looking statements are based
on the current plans and expectations of the Company and are subject to a number
of risks, uncertainties and other factors which could significantly affect
current plans and expectations and the future financial condition and results of
the Company. These factors, which could cause actual results , performance and
achievements to differ materially from those anticipated, include, but are not
limited to:

General Business Conditions

-        general economic and business conditions in the U.S. both nationwide
         and in the states in which we operate hospitals;

-        the competitive nature of the U.S. community hospitals;

-        demographic changes in areas where we operate hospitals;


                                       23
<PAGE>

-        the availability of cash or borrowing to fund working capital,
         renovations and capital improvements at existing hospital facilities
         and for acquisitions and replacement hospital facilities;

-        changes in accounting principles generally accepted in the U.S.; and,

-        fluctuations in the market value of equity securities including SunLink
         common stock;

Operational Factors

-        the availability of, and our ability to attract and retain, sufficient
         qualified staff physicians, management and staff personnel for our
         hospital operations;

-        timeliness of reimbursement payments received under government
         programs;

-        restrictions imposed by debt agreements;

-        the cost and availability of insurance coverage including professional
         liability (e.g., medical malpractice) and general liability insurance;

-        the efforts of insurers, healthcare providers, and others to contain
         healthcare costs;

-        the impact on hospital services of the treatment of patients in lower
         acuity healthcare settings, whether with drug therapy or via
         alternative healthcare services;

-        changes in medical and other technology; and,

-        increases in prices of materials and services utilized in our hospital
         operations;

Liabilities, Claims and Obligations

-        claims under leases, guarantees, and other obligations relating to
         discontinued operations, including sold facilities, retained acquired
         subsidiaries and former subsidiaries;

-        potential adverse consequences of known and unknown government
         investigations;

-        claims for product and environmental liabilities from continuing and
         discontinued operations; and,

-        professional, general, and other claims which may be asserted against
         us;

Regulation and Governmental Activity

-        existing and proposed governmental budgetary constraints:

-        the regulatory environment for our businesses, including state
         certificate of need laws and regulations, rules and judicial cases
         relating thereto;

-        possible changes in the levels and terms of government (including
         Medicare, Medicaid and other programs) and private reimbursement for
         SunLink's healthcare services including the payment arrangements and
         terms of managed care agreements;

-        changes in or failure to comply with Federal, state or local laws and
         regulations affecting the healthcare industry; and,

-        the possible enactment of Federal healthcare reform laws or reform laws
         in states where we operate hospital facilities (including Medicaid
         waivers and other reforms);

Acquisition Related Matters

-        our ability to integrate acquired hospitals and implement our business
         strategy;

-        other risk factors specific to individual transactions, such as and
         including those described in the registration statement we filed with
         respect to the potential merger with HealthMont; and,

-        competition in the market for acquisition of hospitals and healthcare
         facilities.

     Except as required by law, we undertake no obligation to publicly update
these forward-looking statements, whether as a result of new information, future
events or otherwise. The foregoing are significant factors we think could cause
our actual results to differ materially from expected results. However, there
could be other additional factors besides those listed herein that also could
affect SunLink in an adverse manner.


                                       24
<PAGE>

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

         The unaudited Condensed Consolidated Financial Statements herein have
been prepared in accordance with Rule 10-01 of Regulation S-X of the SEC, and as
such, do not include all information required by accounting principles generally
accepted in the United States of America. These Condensed Consolidated Financial
Statements should be read in conjunction with the consolidated financial
statements included in the Company's Annual Report on Form 10-K for the fiscal
year ended June 30, 2002, filed with the SEC on September 16, 2002. In the
opinion of management, the Condensed Consolidated Financial Statements as of and
for the three months ended December 31, 2002, which are unaudited, include all
adjustments, consisting only of normal recurring adjustments, necessary to
present fairly the financial position and results of operations for the periods
indicated. The preparation of these financial statements requires management to
make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results may differ from these estimates
under different assumptions or conditions.

         In January 2002, the SEC issued disclosure guidance for "critical
accounting policies." The SEC defines "critical accounting policies" as those
that require application of management's most difficult, subjective or complex
judgments, often as a result of the need to make estimates about the effect of
matters that are inherently uncertain and may change in subsequent periods.

         The following is not intended to be a comprehensive list of all of our
accounting policies. In many cases, the accounting treatment of a particular
transaction is specifically dictated by accounting principles generally accepted
in the United States of America, with no need for management's judgment in their
application. There are also areas in which management's judgment in selecting an
available alternative would not produce a materially different result.

         We have identified the following as accounting policies critical to us:

         Management Estimates - The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosures of contingent assets
and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period. Some of the more
significant estimates made by management involve reserves for adjustments to net
patient service revenues, evaluation of the recoverability of assets, including
accounts receivable, and the assessment of litigation and contingencies,
including income taxes and related tax asset valuation allowances, all as
discussed in more detail in the remainder of this subsection.

         Net Patient Service Revenues - Like all operators of community
hospitals, we have agreements with third-party payors that provide for payments
at amounts different from established charges. Payment arrangements vary and
include prospectively determined rates per discharge, reimbursed costs,
discounted charges and per diem payments. Our patient service revenues are
reported as services are rendered at the estimated net realizable amounts from
patients, third-party payors, and others. Estimated reductions in revenues to
reflect agreements with third-party payors and estimated retroactive adjustments
under such reimbursement agreements are accrued during the period the related
services are rendered and are adjusted in future periods as interim and final
settlements are determined. Significant changes in reimbursement levels for
services under government and private programs could significantly impact the
estimates used to accrue such revenue deductions.

         Allowance for Doubtful Accounts - Accounts receivable are reduced by an
allowance for amounts estimated to become uncollectable in the future.
Substantially all of the Company's


                                       25
<PAGE>

receivables result from providing healthcare services to hospital facility
patients. The Company's calculation of the allowance for doubtful accounts is
based generally upon our historical collection experience for each type of
payor. The allowance amount is computed by applying allowance percentages to
amounts included in specific payor categories of patient accounts receivable.
Significant changes in reimbursement levels for services under government and
private programs could significantly impact the estimates used to provide the
allowance for doubtful accounts.

         Risk Management - We are exposed to various risks of loss from medical
malpractice and other claims and casualties; theft of, damage to, and
destruction of assets; business interruption; errors and omissions; employee
injuries and illnesses; natural disasters (including earthquakes); and employee
health, dental, and accident benefits. Commercial insurance coverage is
purchased for a portion of claims arising from such matters. When, in our
judgment, claims are sufficiently identified, we accrue a liability for
estimated costs and losses under such claims, net of estimated insurance
recoveries.

         In connection with our acquisition of our existing six hospitals, we
assumed responsibility for professional liability claims reported after February
1, 2001 (acquisition date), and the previous owner retained responsibility for
all known and filed claims prior to the acquisition date. We purchased
claims-made commercial insurance for acts prior to and after the acquisition
date. The recorded liability for professional liability risks includes an
estimate of the liability for claims incurred prior to February 1, 2001, but
reported after February 1, 2001, and for claims incurred after February 1, 2001.
As a component of the related liability for professional liability risks, we
have included the premiums related to the estimated cost of insurance for claims
incurred, but not reported, prior to the acquisition date.

         We self-insure for workers' compensation and employee health risks. The
estimated liability for workers' compensation and employee health risks includes
estimates of the ultimate costs for both reported claims and claims incurred but
not reported. We accrue an estimate of losses resulting from workers'
compensation, employee health and professional liability claims to the extent
they are not covered by insurance. These accruals are estimated quarterly based
upon historical loss patterns.

         We record a liability pertaining to pending litigation based on our
best estimate of a potential loss, if any, or at the minimum end of the range of
loss in circumstances where the range of loss can be reasonably estimated.
Because of uncertainties surrounding the nature of litigation and the ultimate
liability to us, if any, we continually revise our estimated losses as
additional facts become known.

         Income Taxes - We account for income taxes in accordance with Statement
of Financial Accounting Standards ("SFAS") No. 109, Accounting for Income Taxes.
SFAS No. 109 requires an asset and liability approach and the recognition of
deferred tax assets and liabilities for expected future tax consequences. SFAS
No. 109 generally considers all expected future events other than proposed
enactments of changes in the income tax law or rates. We have provided a
valuation allowance for all tax assets so that the net tax asset is zero based
on our assessment, using factors identified in SFAS No. 109, that it is more
likely than not that none of the net deferred tax asset will be realized through
future taxable earnings or implementation of tax planning strategies. Currently,
the most significant tax asset is a U.S. net operating loss carryforward of
approximately $6,300, utilization of which is subject to limitations imposed by
Section 382 of the Internal Revenue Code.


                                       26
<PAGE>




RECENT ACCOUNTING PRONOUNCEMENTS

         In June 2002, the FASB issued SFAS No. 146, Accounting for Costs
Associated with Exit or Disposal Activities. SFAS No. 146 requires the recording
of costs associated with exit or disposal activities at their fair values when a
liability has been incurred. Under previous guidance, certain exit costs were
accrued upon management's commitment to an exit plan, which is generally before
an actual liability has been incurred. SFAS No. 146 is to be applied
prospectively to exit or disposal activities initiated after December 31, 2002.

         In November 2002, the FASB issued FASB Interpretation No. 45,
Guarantor's Accounting and Disclosure Requirements for Guarantees, including
Indirect Guarantees of Indebtedness of Others. This Interpretation elaborates on
disclosures to be made by a guarantor in its financial statements about its
obligations under certain guarantees that it has issued. It also clarifies that
a guarantor is required to recognize, at the inception of a guarantee, a
liability for the fair value of the obligation undertaken in issuing the
guarantee. The initial recognition and measurement provisions of this
Interpretation are applicable on a prospective basis to guarantees issued or
modified after December 31, 2002. The disclosure requirements in this
Interpretation are effective for all financial statements of periods ending
after December 15, 2002. The disclosure requirement of this Interpretation cover
the guarantee by a U.K. subsidiary of SunLink with respect of Beldray's
obligations under a lease covering a portion of Beldray's manufacturing
location. The new disclosure requirements are included in the Discontinued
Operations footnote of the SunLink December 31, 2002 financial statements
included in this report on form 10-Q.

         In December 2002, the FASB issued SFAS No. 148, Accounting for
Stock-Based Compensation - Transition and Disclosure- an amendment of FASB
Statement No. 123. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based
Compensation, to provide alternative methods of transition for a voluntary
change to the fair value based method of accounting for stock-based employee
compensation. In addition, this Statement amends the disclosure requirements of
SFAS No. 123 to require prominent disclosures to both annual and interim
financial statements of the method of accounting for stock-based employee
compensation and the effect of the method used on reported results. This
Statement requires new disclosures about the effect of stock-based compensation
on reported results and also requires those effects be disclosed more
prominently by specifying the form, content and location of those disclosures.
The transition guidance and annual disclosure provisions of SFAS No. 148 are
effective for fiscal years ending after December 15, 2002. The interim
disclosure provisions are effective for financial reports containing financial
statements for interim periods beginning after December 15, 2002. The Company is
currently assessing the impact on its financial statements of this new standard.

RELATED PARTY TRANSACTIONS

         Two directors of SunLink are members of two different law firms, each
of whom provide services to SunLink. We have paid $310 for legal services to
these law firms in the six months ended December 31, 2002.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

         We are exposed to interest rate changes, primarily as a result of
borrowing under the revolving portion of our credit facility. No borrowing was
outstanding on the revolving facility at December 31, 2002. No action has been
taken to cover interest rate market risk, and we are not a party to any interest
rate market risk management activities.


                                       27
<PAGE>

ITEM 4.   EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

         (a)  Evaluation of disclosure controls and procedures - Our Chief
              Executive Officer and our Chief Financial Officer, after
              evaluating the effectiveness of the Company's "disclosure controls
              and procedures" (as defined in the Securities Exchange Act of
              1934, Rules 13a-14(c) and 15-d-14(c) as of a date (the "Evaluation
              Date") within 90 days before the filing date of this quarterly
              report, have concluded that as of the Evaluation Date, our
              disclosure controls and procedures were adequate and designed to
              ensure that material information relating to us and our
              consolidated subsidiaries would be made to them by others within
              those entities.

         (b)  Changes in internal controls - There were no significant changes
              in our internal controls or, to our knowledge, in other factors
              that could significantly affect our disclosure controls and
              procedures subsequent to the Evaluation Date.



                                       28
<PAGE>


PART II.  OTHER INFORMATION

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         On November 22, 2002, the Company held its Annual Meeting of
Shareholders. At the meeting, four directors, Robert M. Thornton, Jr., Karen B.
Brenner, C. Michael Ford and Howard E. Turner were elected to two year terms of
office expiring at the Annual Meeting of Shareholders in 2004. 4,660,423 shares
were voted in favor of electing Mr. Thornton and 21,544 shares were withheld.
4,676,064 shares were voted in favor of electing Ms. Brenner and 5,903 shares
were withheld. 4,678,803 shares were voted in favor of electing Mr. Ford and
3,164 shares were withheld. 4,678,803 shares were voted in favor of electing Mr.
Turner and 3,164 shares were withheld.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(A)      EXHIBITS:

         99.1  -  Chief Executive Officer's Certificate pursuant to 18 U.S.C.
                  Section 1350, as adopted pursuant to Section 906 of the
                  Sarbanes-Oxley Act of 2002.

         99.2  -  Chief Financial Officer's Certificate pursuant to 18 U.S.C.
                  Section 1350, as adopted pursuant to Section 906 of the
                  Sarbanes-Oxley Act of 2002.

(B)      REPORTS ON FORM 8-K - On October 15, 2002, the Company filed a report
         on Form 8-K reporting under "Item 5. Other Events", that on October 15,
         2002, the Company and HM Acquisition Corp., a Delaware corporation and
         wholly owned subsidiary of the Company ("Merger Sub"), entered into an
         Agreement and Plan of Merger with HealthMont, Inc., a Tennessee
         corporation ("HealthMont"), providing for the merger of HealthMont with
         and into the Merger Sub.



                                       29
<PAGE>


                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
SunLink Health Systems, Inc. has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.

                                    SunLink Health Systems, Inc.


                                    By:      /s/ Mark J. Stockslager
                                             -------------------------
                                             Mark J. Stockslager
                                             Principal Accounting Officer



Dated:   February 13, 2003




                                       30
<PAGE>


                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                         OF SUNLINK HEALTH SYSTEMS, INC.


         I, Robert M. Thornton, Jr., President and Chief Executive Officer of
SunLink Health Systems, Inc., certify that:

1.       I have reviewed this quarterly report on Form 10-Q of SunLink Health
         Systems, Inc.

2.       Based on my knowledge, this quarterly report does not contain any
         untrue statement of a material fact or omit to state a material fact
         necessary to make the statements made, in light of the circumstances
         under which such statements were made, not misleading with respect to
         the period covered by this quarterly report.

3.       Based on my knowledge, the financial statements, and other financial
         information included in this quarterly report, fairly present in all
         material respects the financial condition, results of operations and
         cash flows of the registrant as of, and for, the periods presented in
         this quarterly report.

4.       The Registrant's other certifying officers and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant and
         we have:

         a.       designed such disclosure controls and procedures to ensure
                  that material information relating to the Registrant,
                  including its consolidated subsidiaries, is made known to us
                  by others within those entities, particularly during the
                  period in which this quarterly report is being prepared.

         b.       evaluated the effectiveness of the Registrant's disclosure
                  controls and procedures as of a date within 90 days prior to
                  the filing date of the quarterly report (the "Evaluation
                  Date"); and

         c.       presented in this quarterly report our conclusions about the
                  effectiveness of the disclosure controls and procedures based
                  on our evaluation as of the Evaluation Date.

5.       The Registrant's other certifying officers and I have disclosed, based
         on our most recent evaluation, to the Registrant's auditors and audit
         committee of the Registrant's board of directors:

         a.       all significant deficiencies in the design or operation of
                  internal controls which could adversely affect the
                  Registrant's ability to record, process, summarize and report
                  financial data and have identified for the Registrant's
                  auditors any material weaknesses in internal controls; and

         b.       any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  Registrant's internal controls.


                                       31
<PAGE>


6.       The Registrant's other certifying officers and I have indicated in this
         quarterly report whether or not there were any significant changes in
         internal controls or in other factors that could significantly affect
         internal controls subsequent to the date of our most recent evaluation,
         including any corrective actions with regard to significant
         deficiencies and material weaknesses.


                                    Date:  February 13, 2003



                                    /s/ Robert M. Thornton, Jr.
                                    ------------------------------
                                    Robert M. Thornton, Jr.
                                    President and Chief Executive Officer



                                       32
<PAGE>



                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                         OF SUNLINK HEALTH SYSTEMS, INC.

         I, Joseph T. Morris, Chief Financial Officer of SunLink Health Systems,
Inc., certify that:

1.       I have reviewed this quarterly report on Form 10-Q of SunLink Health
         Systems, Inc.

2.       Based on my knowledge, this quarterly report does not contain any
         untrue statement of a material fact or omit to state a material fact
         necessary to make the statements made, in light of the circumstances
         under which such statements were made, not misleading with respect to
         the period covered by this quarterly report.

3.       Based on my knowledge, the financial statements, and other financial
         information included in this quarterly report, fairly present in all
         material respects the financial condition, results of operations and
         cash flows of the registrant as of, and for, the periods presented in
         this quarterly report.

4.       The Registrant's other certifying officers and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant and
         we have:

         a.       designed such disclosure controls and procedures to ensure
                  that material information relating to the Registrant,
                  including its consolidated subsidiaries, is made known to us
                  by others within those entities, particularly during the
                  period in which this quarterly report is being prepared.

         b.       evaluated the effectiveness of the Registrant's disclosure
                  controls and procedures as of a date within 90 days prior to
                  the filing date of the quarterly report (the "Evaluation
                  Date"); and

         c.       presented in this quarterly report our conclusions about the
                  effectiveness of the disclosure controls and procedures based
                  on our evaluation as of the Evaluation Date.

5.       The Registrant's other certifying officers and I have disclosed, based
         on our most recent evaluation, to the Registrant's auditors and audit
         committee of the Registrant's board of directors:

         a.       all significant deficiencies in the design or operation of
                  internal controls which could adversely affect the
                  Registrant's ability to record, process, summarize and report
                  financial data and have identified for the Registrant's
                  auditors any material weaknesses in internal controls; and

         b.       any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  Registrant's internal controls.


                                       33
<PAGE>



6.       The Registrant's other certifying officers and I have indicated in this
         quarterly report whether or not there were any significant changes in
         internal controls or in other factors that could significantly affect
         internal controls subsequent to the date of our most recent evaluation,
         including any corrective actions with regard to significant
         deficiencies and material weaknesses.


                                             Date:  February 13, 2003


                                             /s/ Joseph T. Morris
                                             -------------------------
                                             Joseph T. Morris
                                             Chief Financial Officer



                                       34